We also examined the portion of GBM-associated newly-formed microvessels by the assessment of the ratios between the expression of CD105 and pan-endothelial markers (CD105/CD31, CD105/CD34, and CD105/vWF) and their relation to VEGF and HIF2α. The gene discussed is PECAM1; the disease is glioblastoma.